Suppr超能文献

肥胖对肝硬化合并感染性休克患者的影响:一项回顾性队列研究。

The impact of obesity in cirrhotic patients with septic shock: A retrospective cohort study.

机构信息

Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada.

Department of Critical Care Medicine, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Liver Int. 2018 Jul;38(7):1230-1241. doi: 10.1111/liv.13648. Epub 2017 Dec 18.

Abstract

BACKGROUND & AIMS: The prevalence of obesity in cirrhosis is rising. The impact of obesity in critically ill cirrhotic patients with sepsis/septic shock has not been evaluated. This study aimed to examine the relationship between obesity and mortality in cirrhotic patients admitted to the intensive care unit with septic shock.

METHODS

A retrospective cohort study of all cirrhotic patients with septic shock (n = 362) and a recorded body mass index (BMI) from an international, multicentre (CATSS) database (1996-2015) was performed. Patients were classified by BMI as per WHO categories. Primary outcome was in-hospital mortality. Multivariate logistic regression analyses were carried out to determine independent associations with outcome.

RESULTS

In this analysis, mean age was 56.4 years, and 62% were male. Median BMI was 26.3%, and 57.7% were overweight/obese. In-hospital mortality was 71%. Obese patients were more likely to have comorbidities of cardiac disease, lung disease and diabetes. Compared to survivors (n = 105), non-survivors (n = 257) had significantly higher MELD and APACHEII scores and higher requirements for renal replacement therapy and mechanical ventilation (P < .03 for all). Using multivariable logistic regression, increase in BMI (OR 1.07, P = .034), time delay to appropriate antimicrobials (OR 1.16 per hour, P = .003), APACHEII (OR 1.12 per unit, P = .008) and peak lactate (OR 1.15, P = .028) were independently associated with in-hospital mortality.

CONCLUSIONS

Septic shock in cirrhosis carries a high mortality. Increased BMI is common in critically ill cirrhotic patients and independently associated with increased in-hospital mortality.

摘要

背景与目的

肝硬化患者肥胖的患病率正在上升。肥胖对患有脓毒症/感染性休克的重症肝硬化患者的影响尚未得到评估。本研究旨在研究入住重症监护病房的患有感染性休克的肝硬化患者中肥胖与死亡率之间的关系。

方法

对来自国际多中心 CATSS 数据库(1996-2015 年)的所有患有感染性休克的肝硬化患者(n=362)进行回顾性队列研究,其中记录了体重指数(BMI)。患者按 BMI 分为世卫组织类别。主要结局为院内死亡率。进行多变量逻辑回归分析以确定与结局的独立关联。

结果

在这项分析中,患者的平均年龄为 56.4 岁,62%为男性。中位 BMI 为 26.3%,57.7%超重/肥胖。院内死亡率为 71%。肥胖患者更有可能患有心脏病、肺病和糖尿病等合并症。与幸存者(n=105)相比,非幸存者(n=257)的 MELD 和 APACHEII 评分明显更高,需要肾脏替代治疗和机械通气的比例更高(所有 P 值均<0.03)。使用多变量逻辑回归,BMI 增加(OR 1.07,P=0.034)、适当使用抗生素的时间延迟(每小时增加 1.16,P=0.003)、APACHEII(每增加 1 个单位增加 1.12,P=0.008)和峰值乳酸(OR 1.15,P=0.028)与院内死亡率独立相关。

结论

肝硬化合并感染性休克死亡率较高。危重症肝硬化患者中 BMI 增加很常见,并且与院内死亡率增加独立相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验